Clearance Summary
R3 Anteverted Liners received FDA 510(k) clearance under submission number K182535, sponsored by Smith & Nephew, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2018-11-19.
- Submission: K182535
- Applicant / Sponsor: Smith & Nephew, Inc.
- Clearance pathway: Special
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3358
- Decision date: 2018-11-19
Classification & Regulation
This clearance is catalogued under FDA product code MBL and 21 CFR 888.3358, within the Orthopedic review panel as a Class II device.